Endo H, Hagihara Y, Kimura N, Takizawa K, et al. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg 2022 Apr 1:1-11. doi: 10.3171/2022.2.JNS212914.
PMID: 35364589